Cargando…

Central Nervous System-related Conditions and Associated Healthcare Resource Use Among Japanese nmCRPC Patients Based on Retrospective Claims Data

Background: Japanese patients with prostate cancer are typically treated with primary androgen deprivation therapy (ADT), most commonly administered as a combination of a luteinizing hormone-releasing hormone (LHRH) agonist and an antiandrogen (AA). Since LHRH agonists and AA therapy can be maintain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ledesma, Dianne A., Chua, Jonathan L., Tang, Susan S.H., Lim, Xiu W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621534/ https://www.ncbi.nlm.nih.gov/pubmed/37928821 http://dx.doi.org/10.36469/001c.87550

Ejemplares similares

Conceptual assessment of HRQOL among Japanese non‐metastatic castration‐resistant prostate cancer (nmCRPC) patients
por: Nishimura, Kazuo, et al.
Publicado: (2022)

Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
por: Cattrini, Carlo, et al.
Publicado: (2022)

Emerging Proteins in CRPC: Functional Roles and Clinical Implications
por: Kong, Piaoping, et al.
Publicado: (2022)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
por: Stephan, Anna-Janina, et al.
Publicado: (2022)

Unmet needs in non-metastatic castration-resistant prostate cancer from the Japanese patient perspective: a discrete choice experiment
por: Uemura, Hiroji, et al.
Publicado: (2021)

Complications, Costs, and Healthcare Resource Utilization After Staged, Delayed, and Immediate Free-Flap Breast Reconstruction: A Longitudinal, Claims-Based Analysis
por: Shammas, Ronnie L., et al.
Publicado: (2022)

BRAF Alteration in Central and Peripheral Nervous System Tumors
por: Srinivasa, Komal, et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Pathogenesis of central nervous system germ cell tumors
por: Liu, Siyuan, et al.
Publicado: (2022)

Immune Responses to Non-Tumor Antigens in the Central Nervous System
por: Huber, Amanda K., et al.
Publicado: (2014)

Editorial: Mechanisms and Therapy for Cancer Metastasis to the Central Nervous System
por: Zhao, Haotian, et al.
Publicado: (2019)

Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib
por: Petrylak, Daniel P., et al.
Publicado: (2022)

Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
por: Singh, Mohini, et al.
Publicado: (2017)

Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Immunotherapy associated central nervous system complications in primary brain tumors
por: Mantica, Megan, et al.
Publicado: (2023)

Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline
por: Lim-Fat, Mary Jane, et al.
Publicado: (2022)

Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen)
por: Belli, Maria Luisa, et al.
Publicado: (2020)

Is the Concept of Central Nervous System Immune Privilege Irrelevant in the Setting of Acute Infection?
por: Huber, Amanda K., et al.
Publicado: (2015)

Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies
por: D’Souza, Neil M., et al.
Publicado: (2016)

Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease
por: Kamath, Suneel D., et al.
Publicado: (2018)

The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma
por: Zhou, Xiaolan, et al.
Publicado: (2020)

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside
por: Shao, Liang, et al.
Publicado: (2021)

Clinical and pathological factors and outcome of central nervous system metastasis in breast cancer
por: Dettwiler, Dimitri, et al.
Publicado: (2023)

Systematically understanding the immunity leading to CRPC progression
por: Ji, Zhiwei, et al.
Publicado: (2019)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

Comparing costs and health care resource utilization between nmHSPC and mHSPC patients: a retrospective claims analysis
por: Ko, Gilbert Chao, et al.
Publicado: (2022)

The Emerging Role of D-2-Hydroxyglutarate as an Oncometabolite in Hematolymphoid and Central Nervous System Neoplasms
por: Rakheja, Dinesh, et al.
Publicado: (2013)

Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance
por: Sammartano, Vincenzo, et al.
Publicado: (2022)

The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma
por: Chen, Fan, et al.
Publicado: (2022)

Editorial: Advances of radiomics and artificial intelligence in the management of patients with central nervous system tumors
por: Chen, Ziyan, et al.
Publicado: (2023)

Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
por: Hendriks, Lizza E. L., et al.
Publicado: (2018)

Overexpression of EGFR and TGFα in von Hippel–Lindau-Related Central Nervous System Hemangioblastomas
por: Liu, Zhen, et al.
Publicado: (2020)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

Clear Cell Meningioma in the Central Nervous System: Analysis of Surveillance, Epidemiology, and End Results Database
por: Wang, Yubo, et al.
Publicado: (2021)

Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report
por: Zhang, Xuzhao, et al.
Publicado: (2021)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_20fd9g69u888dpep9rfqqkt19e